StockGlow

Lipella Pharmaceuticals Inc. (LIPO)

Reformulates existing drugs into new treatments for rare diseases and conditions.

$0.03+0.00%Healthcare
Compare LIPO with
StockGlow Score
4
Bearish
BearishBullish
1 year ago-95.4%

The outlook

LIPO trades at $0.033, sitting near its 52-week low with the price well below both its 50- and 200-day moving averages. Analyst coverage appears thin for this micro-cap biotech stock. Current market positioning reflects a bearish lean overall.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Market cap
$152,487
52-wk high
$0.74
52-wk low
$0.02
50-day avg
$0.08
200-day avg
$0.19
Trailing P/E
—

Similar stocks

ZVSAZyVersa Therapeutics, Inc.$0.12+0.00%PXMDPaxMedica, Inc.$0.00+0.00%DRMADermata Therapeutics, Inc.$1.24-4.99%TNONTenon Medical, Inc.$0.19+3.26%CDIOCardio Diagnostics Holdings, Inc.$1.56-3.70%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy